tremelimumab

Spain

Drugs containing this active substance

  • IMJUDO 20 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION

    It is used to treat a type of liver cancer (advanced or unresectable hepatocellular carcinoma) in combination with durvalumab, and also to treat a type of advanced non-small cell lung cancer in adults, in combination with other medicines.

    Form: solution for infusion, concentrate

    Active substance Dosage
    tremelimumab 300 mg

    ATC: L01F L01FX L01FX20

    Manufacturer: Astrazeneca Ab